University of Maryland School of Medicine logo
Emergency Medicine
All Departments
UMSOM Assistant
UMEM Educational Pearls
  • Home
  • Departments
  • Emergency Medicine
  • CME
  • UMEM Educational Pearls
  • CME
  • Courses and Conferences
  • Free Open Access Medical Education
  • UMEM Educational Pearls

Search

Title: Valproic Acid and Status Epilepticus

Category: Critical Care

Posted: 1/26/2011 by Mike Winters, MBA, MD (Updated: 7/21/2026)

Valproic Acid in Status Epilepticus

  • In previous pearls, we have discussed the treatment of status epilepticus (SE) with first-line (benzodiazepines) and second-line agents (phenytoin/fosphenytoin).
  • Refractory SE is defined as the failure to respond to both first- or second-line antiepileptic medications.
  • Valproic acid is listed in many algorithms as a third-line agent for treating SE.
  • Avoid valproic acid in refractory SE patients who have hepatic disease or dysfunction.
  • Although rare, valproic acid can cause a fatal hepatotoxicity in these patients. 

References

Pillow MT, Malani N. Best practices for seizure management in the emergency department.  ACEP News 2011; 30(1):14-16.


University of Maryland School of Medicine logo
  • Departments
  • Programs
  • Research Centers
  • Institutes
  • Graduate Education
  • CIBR Cores
  • Offices of the Dean
    • University of Maryland, Baltimore
    • University of Maryland Medical Center
    • Medical Alumni Association of the University of Maryland
    • Health Sciences and Human Services Library
University of Maryland School of Medicine
655 W. Baltimore Street
Baltimore, MD 21201
Contact Us

© University of Maryland School of Medicine

    • Webmaster
    • Web Accessibility
    • Site Index
    • UMB Hotline
    • Employment
    • Map